Epidermal Growth Factor (EGF)
Active synthesis of epidermal growth factor in human mammary glands
5
Nitric oxide from inflammatory origin impairs neural stem cell proliferation by inhibiting epidermal growth factor receptor signaling
14
Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival
9
Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
12
Chemical genomic-based pathway analyses for epidermal growth factor-mediated signaling in migrating cancer cells.
7
Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
17
Epidermal growth factor receptors, testosterone levels and parotid gland changes in rats infected with Trypanosoma cruzi
5
Epidermal growth factor signalling controls myosin II planar polarity to orchestrate convergent extension movements during Drosophila tubulogenesis.
17
Autonomous growth of BALBMK keratinocytes transfected with a retroviral vector carrying the human epidermal growth factor gene
5
A temporal signature of epidermal growth factor signaling regulates the differentiation of germline cells in testes of Drosophila melanogaster.
12
Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras
10
Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context.
7
Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor.
13
Transgenic Soybean Production of Bioactive Human Epidermal Growth Factor (EGF).
17
Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.
15
Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
12
The expression of the epidermal growth factor (EGF) during odontogenesis:
7
Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation.
20
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
13
AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits antitumor activity both in vitro and in vivo.
10